Contact this trialFirst, we need to learn more about you.
Procedure
Stem Cell Transplant with Conditioning Regimen for Blood Diseases
Recruiting1 awardPhase 2
Seattle, Washington
This trial will study whether a new, less intensive conditioning regimen using the drugs treosulfan, thiotepa, and fludarabine phosphate is just as effective in treating patients with nonmalignant diseases as the current standard of care, which uses more powerful and potentially more toxic chemotherapy drugs.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service